MetaCap

Eocene (EOCN) vs Genprex (GNPX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Genprex is the larger company by market cap ($1.9 million vs $1.9 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

EOCN-48.52%GNPX-44.66%
+8%-22%-52%
Oct 7, 20261 yearNov 20, 2026
EOCN-49.71%GNPX-46.69%
+2%-25%-52%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

EOCN versus GNPX key metrics
MetricEOCNGNPX
Share price$1.78$1.45
Market cap$1.90M$1.94M
1-day change+1.73%-13.17%
P/E ratio (TTM)—0.01
EPS (TTM)$-15.21$98.47
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-10.31M$-16.23M
52-week high$10.08$80.96
52-week low$1.75$1.45
Distance from 52-week high-82.34%-98.21%
Analyst consensusnone—
Average volume18.17K168.88K
Shares outstanding1.07M1.33M
Employees313
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Eocene

EOCN stock →

Eocene Ltd. a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications.

Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees

About Genprex

GNPX stock →

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes.

Health Care · Biotechnology: Pharmaceutical Preparations · 13 employees

EOCN vs GNPX FAQ

Which is bigger, Eocene or Genprex?

Genprex (GNPX) is larger, with a market capitalization of $1.94M compared with $1.90M for Eocene (EOCN).

Are Eocene and Genprex in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons